Showing results (141-150 of 230) with videos related to
Sort By:
Pageof 23
Gynecologic Oncology|January 7, 2025
Incorporating immune checkpoint inhibitors in epithelial ovarian cancerGiorgio Bogani, Kathleen N Moore, Isabelle Ray-Coquard, et al.Veterinary Journal (London, England : 1997)|October 4, 2011
Apparent prevalence of antibodies to Coxiella burnetii (Q fever) in bulk tank milk from dairy herds in southern BelgiumGuy Czaplicki, Jean-Yves Houtain, Cédric Mullender, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast CancerFelipe Batalini, Niya Xiong, Nabihah Tayob, et al.Gynecologic Oncology|June 8, 2024
Feasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trialRachel A Pozzar, Andrea C Enzinger, Catherine Howard, et al.Cancer|April 8, 2015
NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancerAkila N Viswanathan, Jennifer Moughan, Brigitte E Miller, et al.Gynecologic Oncology|February 27, 2021
Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivorsElizabeth Schrier, Niya Xiong, Embree Thompson, et al.Cancer|September 8, 2016
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)Vicky Makker, Fernando O Recio, Ling Ma, et al.Gynecologic Oncology|July 15, 2014
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinomaRichard T Penson, Kathleen M Moore, Gini F Fleming, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2026
Transcriptional signatures indicating RB function correlate with response to CDK4/6 inhibition in endometrial cancerZelei Yang, Upendra Raj Bhattarai, Martin K Hayes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian CancerLarissa A Meyer, Angel M Cronin, Charlotte C Sun, et al.Pageof 23